pre-IPO PHARMA

COMPANY OVERVIEW

Cycle Pharmaceuticals is a pioneering pharmaceutical company, reimagining how drugs can benefit patients, to improve the efficacy of their treatments and their quality of life at every stage.


LOCATION

  • Cambridge, , UK
  • Boston, MA, USA

  • THERAPEUTIC AREAS


    WEBSITE

    https://cyclepharma.com


    CAREER WEBSITE

    https://cyclepharma.com/careers/


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Jan 17, 2023

    Multiple Sclerosis Patients in US Left Without Essential Patient Support Program Will Now Receive Equivalent Backing From Cycle Pharmaceuticals Following FDA’s Approval of TASCENSO ODT (fingolimod)


    Nov 25, 2021

    Global 3D Printed Drugs Market Research Report 2021-2027 Featuring GlaxoSmithKline, Hewlett Packard Caribe, Aprecia Pharmaceuticals, 3D Printer Drug Machine, FabRx, Cycle Pharmaceuticals - ResearchAndMarkets.com


    Sep 28, 2021

    Cycle Pharmaceuticals launches SAJAZIRTM (icatibant) Injection, a new treatment option in Hereditary Angioedema (HAE)


    Sep 13, 2021

    Cycle Pharmaceuticals Launches Cycle Vita™, a Dedicated Support Platform for Rare Disease Patients


    Sep 8, 2020

    Cycle Pharmaceuticals Features in the Sunday Times Tech Track Ones to Watch 2020


    For More Press Releases


    Google Analytics Alternative